Blonder Tongue Laboratories Inc
BDR was delisted on the 24th of June, 2022.
6 hedge funds and large institutions have $184K invested in Blonder Tongue Laboratories Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6% less capital invested
Capital invested by funds: $195K → $184K (-$11K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$20.1K |
| 2 |
Renaissance Technologies
New York
|
+$540 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$76.5K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$8K |
BDR Hedge Fund Activity: Q1 2017 in Review
6 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q1 2017, worth a combined $184K — down 5.6% from $195K a quarter earlier.
Fund positioning in BDR was balanced in Q1 2017: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $20.1K. The largest seller was UBS Group, cutting an estimated $76.5K.
- 6 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $184K of Blonder Tongue Laboratories Inc stock for Q1 2017, down 5.6% quarter-over-quarter.
- 1 fund opened new Blonder Tongue Laboratories Inc positions in Q1 2017 and 1 closed out, a net change of 0 holders.
- The largest Blonder Tongue Laboratories Inc buyer in Q1 2017 was Citadel Advisors, an estimated $20.1K added.
- The largest Blonder Tongue Laboratories Inc seller in Q1 2017 was UBS Group, an estimated $76.5K sold.
Based on aggregated 13F filings for Q1 2017.